Delegates at the 2022 Interim Meeting
·
32 MIN READ

Highlights from the 2022 AMA Interim Meeting

Catch up with the news and key moments from the AMA House of Delegates’ meeting, which ran Nov. 12–15.

Interim Meeting
Delegates stand in line to speak at the 2022 Interim Meeting
·
3 MIN READ

Harm-reduction efforts needed to curb overdose epidemic

AMA backs greater use of point-of-care fentanyl test strips and using opioid-litigation settlement funds to boost physician training. Learn more.

Overdose Epidemic
·
2 MIN READ

AMA to urge using opioid litigation funds to train physicians in opioid treatment

The AMA expanded its opioid litigation policy to emphasize using a portion of the settlement funds to expand physician training for treating opioid use disorder.

Press Releases
·
3 MIN READ

AMA adopts new policies during first day of voting at interim meeting

New policies support a Medicare Advantage database of physicians and oversight of Third-Party Administrators.

Press Releases
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Nov. 7, 2022

In the news: Complications from SARS-COV-2 reinfections, Uptick of sleep problems among U.S. adults, adolescents vaping younger, more intensely and more.

Publications & Newsletters
·
14 MIN READ

Nov. 11, 2022: National Advocacy Update

Bipartisan House letter coincides with launch of APM coalition and more in the latest National Advocacy Update.

Advocacy Update
Narcan kit
·
3 MIN READ

FDA naloxone guidance helps harm-reduction groups’ work to save lives

Learn how new clarity from the FDA on burdensome requirements for bulk purchase of naloxone aid underserved communities.

Overdose Epidemic
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Oct. 31, 2022

In the news: CDC updates opioid prescribing guidelines, monkeypox transmission may occur presymptomatically, flu-related hospitalizations reach new heights and more.

Publications & Newsletters
People in conference room, seen through semi-opaque glass wall
·
4 MIN READ

How the 10 largest PBMs hold huge sway in health care marketplace

First-of-its-kind data on pharmacy benefit managers (PBMs) analyzed in AMA report shows widespread, high market concentration.

Access to Care